Latest Breaking News On - Dosing commenced - Page 1 : vimarsana.com

Announced Positive Topline Results from CT1812 Phase 2 SEQUEL Study in Mild-to-Moderate Alzheimer’s Disease

Casey mcdonaldDaniel kontoh boatengLisa ricciardiSteven weissmanInternational journal of molecular scienceAlzheimer association international conferenceCompany or cognitionNational institute onCognition therapeutics incTiberend strategic advisors incSecurities exchange commissionAssociation for researchAnnounced positive topline resultsMild to moderate alzheimerEarly alzheimerAffirming target engagement